| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.15 | 0.5 |